-
COVID-19 Delays Planned Trial of Friedreich’s Ataxia Therapy, PTC Says
PTC Therapeutics said pandemic will delay, by about 3 months, plans for a clinical trial in Friedreich’s ataxia patients of PTC743 and gene therapy work. Find out more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.